CVS GROUP PLC

Share Issue/Capital Change • Aug 26, 2021

National Storage Mechanism | Additional information

RNS Number : 8743J

CVS Group plc

26 August 2021

CVS Group plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Block Listing Application

CVS, one of the UK's leading providers of integrated veterinary services, announces that an application has been made to the Financial Conduct Authority and the London Stock Exchange for the admission of 297,604 of its ordinary shares of 0.2p each in the Company ("Ordinary Shares") to trading on AIM.

The Ordinary Shares will be reserved under a block listing and will be issued in connection with the grant, vesting and/or exercise of awards under the terms of the following employee share schemes:

·    296,069 Ordinary Shares pursuant to the CVS Group plc 2018-2021 SAYE Sharesave Scheme (the "2022 Scheme")

·    1,535 Ordinary Shares pursuant to the CVS Group plc 2017-2020 SAYE Sharesave Scheme (the "2021 Scheme")

When issued, the Ordinary Shares under the block listing will rank pari passu with the Company's existing issued Ordinary Shares. It is anticipated that the shares will be admitted on 1 September 2021.

Contacts:
CVS Group plc	via MHP Communications
Richard Fairman, CEO
Jenny Farrer, Company Secretary
Singer Capital Markets (Nominated Adviser & Broker)	+44 20 7496 3000
Aubrey Powell / Jen Boorer / Rachel Hayes
MHP Communications (Financial PR)	+44 20 3128 8549
Andrew Jaques / Rachel Mann / Charles Hirst

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSPFMRTMTITMFB